Michael Zinda is an Oncology physician affiliated with Io Therapeutics. OpenAlex indexes 191 publications with 4,093 citations (h-index 34).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1104 John Nolen Dr
Madison, WI 537131430
Telephone
608-251-6868Registry record last updated 7 Mar 2023.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Discovery of the Potent and Selective ATR Inhibitor Camonsertib (RP-3500)
Journal of Medicinal Chemistry
2024 - Detection of Biallelic Loss of DNA Repair Genes in Formalin-Fixed, Paraffin-Embedded Tumor Samples Using a Novel Tumor-Only Sequencing Panel
Journal of Molecular Diagnostics
2023 - <i>ATM</i> Germline-Mutated Gastroesophageal Junction Adenocarcinomas: Clinical Descriptors, Molecular Characteristics, and Potential Therapeutic Implications
JNCI Journal of the National Cancer Institute
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Mark Dinubile
Io Therapeutics
Joseph Tauber, MD
Io Therapeutics
Khushboo Sheth, MB, BS
Io Therapeutics
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”